CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 4 Grant or award CFO & COO acquired 39,350 shares (grant or award)
- 4 Open-market sale 10% owner sold 134,558 shares at an average $1.50 ($202,209)
- 4 Open-market sale 10% owner sold 26,555 shares at an average $1.83 ($48,726)
- 4 Open-market sale 10% owner sold 21,550 shares at an average $1.94 ($41,826)
- 4 Open-market sale 10% owner sold 18,760 shares at an average $2.07 ($38,740)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 31,916 shares at an average $2.26 ($72,189)
- 4 Open-market sale 10% owner sold 116,476 shares at an average $2.29 ($266,870)
- 4 Open-market sale 10% owner sold 67,427 shares at an average $2.37 ($159,500)
- 4 Open-market sale 10% owner sold 291,152 shares at an average $2.36 ($688,499)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 1,333,333 shares at $6.00 ($7,999,998)
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
Page 34 of 40 · 798 filings